Polymer Drugs in the Clinical Stage: Advantages and Prospects
Proceedings of the International Symposium on Polymer Therapeutics - Recent Progress in Clinics and Future Prospects, held July 13-14, 2001, in Nara, Japan. The technology of polymer science has developed considerably during the past half-century, and this volume describes some of the aspects of thi...
Gespeichert in:
| Weitere Verfasser: | , , , |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Boston, MA
Springer US
2003
|
| Schriftenreihe: | Advances in Experimental Medicine and Biology
519 |
| Schlagworte: | |
| Online-Zugang: | UBR01 URL des Erstveröffentlichers |
| Zusammenfassung: | Proceedings of the International Symposium on Polymer Therapeutics - Recent Progress in Clinics and Future Prospects, held July 13-14, 2001, in Nara, Japan. The technology of polymer science has developed considerably during the past half-century, and this volume describes some of the aspects of this technology that will have a great impact in the future. Among these advances, for example, are gene delivery to specific disease sites and carrier polymers that respond to a stimulus or particular environment. Cancer targeted drug delivery is another focused area of this volume because of the important nature of EPR-effect of polymer drugs in tumor. Included are discussions of as many examples as possible of polymer drugs that have achieved, or are close to clinical use. The concept of "Polymer drugs" here is limited to primarily injectable and water-soluble agents, although also covered are some drugs in micellar form or liposomes. This book is intended for students and researchers in the field of pharmacology who have particular interests in drug delivery, targeting, and formulation, as well as for clinicians such as oncologists who are interested in the field. People who work at regulatory agencies should also be aware such that drugs with great potential are being developed and will be beneficial to many patients, as well as to health insurance agencies because of improved cost effectiveness |
| Beschreibung: | 1 Online-Ressource (VIII, 226 p) |
| ISBN: | 9780306479328 |
| DOI: | 10.1007/b105364 |
Internformat
MARC
| LEADER | 00000nmm a2200000zcb4500 | ||
|---|---|---|---|
| 001 | BV046148352 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 190906s2003 |||| o||u| ||||||eng d | ||
| 020 | |a 9780306479328 |9 978-0-306-47932-8 | ||
| 024 | 7 | |a 10.1007/b105364 |2 doi | |
| 035 | |a (ZDB-2-SBL)978-0-306-47932-8 | ||
| 035 | |a (OCoLC)1119032499 | ||
| 035 | |a (DE-599)BVBBV046148352 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-355 | ||
| 082 | 0 | |a 615 |2 23 | |
| 084 | |a VX 8560 |0 (DE-625)147831:253 |2 rvk | ||
| 245 | 1 | 0 | |a Polymer Drugs in the Clinical Stage |b Advantages and Prospects |c edited by Hiroshi Maeda, Alexander Kabanov, Kazunori Kataoka, Teruo Okano |
| 264 | 1 | |a Boston, MA |b Springer US |c 2003 | |
| 300 | |a 1 Online-Ressource (VIII, 226 p) | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 490 | 0 | |a Advances in Experimental Medicine and Biology |v 519 | |
| 520 | |a Proceedings of the International Symposium on Polymer Therapeutics - Recent Progress in Clinics and Future Prospects, held July 13-14, 2001, in Nara, Japan. The technology of polymer science has developed considerably during the past half-century, and this volume describes some of the aspects of this technology that will have a great impact in the future. Among these advances, for example, are gene delivery to specific disease sites and carrier polymers that respond to a stimulus or particular environment. Cancer targeted drug delivery is another focused area of this volume because of the important nature of EPR-effect of polymer drugs in tumor. Included are discussions of as many examples as possible of polymer drugs that have achieved, or are close to clinical use. The concept of "Polymer drugs" here is limited to primarily injectable and water-soluble agents, although also covered are some drugs in micellar form or liposomes. This book is intended for students and researchers in the field of pharmacology who have particular interests in drug delivery, targeting, and formulation, as well as for clinicians such as oncologists who are interested in the field. People who work at regulatory agencies should also be aware such that drugs with great potential are being developed and will be beneficial to many patients, as well as to health insurance agencies because of improved cost effectiveness | ||
| 650 | 4 | |a Pharmacology/Toxicology | |
| 650 | 4 | |a Polymer Sciences | |
| 650 | 4 | |a Medical Biochemistry | |
| 650 | 4 | |a Oncology | |
| 650 | 4 | |a Pharmacy | |
| 650 | 4 | |a Toxicology | |
| 650 | 4 | |a Polymers | |
| 650 | 4 | |a Biochemistry | |
| 650 | 4 | |a Oncology | |
| 650 | 4 | |a Pharmacy | |
| 650 | 0 | 7 | |a Polymere |0 (DE-588)4046699-1 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Arzneistoffträger |0 (DE-588)4278196-6 |2 gnd |9 rswk-swf |
| 655 | 7 | |8 1\p |0 (DE-588)1071861417 |a Konferenzschrift |y 2001 |z Nara |2 gnd-content | |
| 689 | 0 | 0 | |a Polymere |0 (DE-588)4046699-1 |D s |
| 689 | 0 | 1 | |a Arzneistoffträger |0 (DE-588)4278196-6 |D s |
| 689 | 0 | |8 2\p |5 DE-604 | |
| 700 | 1 | |a Maeda, Hiroshi |4 edt | |
| 700 | 1 | |a Kabanov, Alexander |4 edt | |
| 700 | 1 | |a Kataoka, Kazunori |4 edt | |
| 700 | 1 | |a Okano, Teruo |4 edt | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9781475778403 |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9780306474712 |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9781475778397 |
| 856 | 4 | 0 | |u https://doi.org/10.1007/b105364 |x Verlag |z URL des Erstveröffentlichers |3 Volltext |
| 912 | |a ZDB-2-SBL | ||
| 940 | 1 | |q ZDB-2-SBL_2000/2004 | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-031528529 | ||
| 883 | 1 | |8 1\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
| 883 | 1 | |8 2\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
| 966 | e | |u https://doi.org/10.1007/b105364 |l UBR01 |p ZDB-2-SBL |q ZDB-2-SBL_2000/2004 |x Verlag |3 Volltext | |
Datensatz im Suchindex
| _version_ | 1804180488499232768 |
|---|---|
| any_adam_object | |
| author2 | Maeda, Hiroshi Kabanov, Alexander Kataoka, Kazunori Okano, Teruo |
| author2_role | edt edt edt edt |
| author2_variant | h m hm a k ak k k kk t o to |
| author_facet | Maeda, Hiroshi Kabanov, Alexander Kataoka, Kazunori Okano, Teruo |
| building | Verbundindex |
| bvnumber | BV046148352 |
| classification_rvk | VX 8560 |
| collection | ZDB-2-SBL |
| ctrlnum | (ZDB-2-SBL)978-0-306-47932-8 (OCoLC)1119032499 (DE-599)BVBBV046148352 |
| dewey-full | 615 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 615 - Pharmacology and therapeutics |
| dewey-raw | 615 |
| dewey-search | 615 |
| dewey-sort | 3615 |
| dewey-tens | 610 - Medicine and health |
| discipline | Chemie / Pharmazie Medizin |
| doi_str_mv | 10.1007/b105364 |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03840nmm a2200661zcb4500</leader><controlfield tag="001">BV046148352</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">190906s2003 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780306479328</subfield><subfield code="9">978-0-306-47932-8</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/b105364</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-2-SBL)978-0-306-47932-8</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1119032499</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV046148352</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615</subfield><subfield code="2">23</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">VX 8560</subfield><subfield code="0">(DE-625)147831:253</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Polymer Drugs in the Clinical Stage</subfield><subfield code="b">Advantages and Prospects</subfield><subfield code="c">edited by Hiroshi Maeda, Alexander Kabanov, Kazunori Kataoka, Teruo Okano</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Boston, MA</subfield><subfield code="b">Springer US</subfield><subfield code="c">2003</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (VIII, 226 p)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Advances in Experimental Medicine and Biology</subfield><subfield code="v">519</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Proceedings of the International Symposium on Polymer Therapeutics - Recent Progress in Clinics and Future Prospects, held July 13-14, 2001, in Nara, Japan. The technology of polymer science has developed considerably during the past half-century, and this volume describes some of the aspects of this technology that will have a great impact in the future. Among these advances, for example, are gene delivery to specific disease sites and carrier polymers that respond to a stimulus or particular environment. Cancer targeted drug delivery is another focused area of this volume because of the important nature of EPR-effect of polymer drugs in tumor. Included are discussions of as many examples as possible of polymer drugs that have achieved, or are close to clinical use. The concept of "Polymer drugs" here is limited to primarily injectable and water-soluble agents, although also covered are some drugs in micellar form or liposomes. This book is intended for students and researchers in the field of pharmacology who have particular interests in drug delivery, targeting, and formulation, as well as for clinicians such as oncologists who are interested in the field. People who work at regulatory agencies should also be aware such that drugs with great potential are being developed and will be beneficial to many patients, as well as to health insurance agencies because of improved cost effectiveness</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmacology/Toxicology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Polymer Sciences</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medical Biochemistry</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Oncology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmacy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Toxicology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Polymers</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Biochemistry</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Oncology </subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmacy</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Polymere</subfield><subfield code="0">(DE-588)4046699-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneistoffträger</subfield><subfield code="0">(DE-588)4278196-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="8">1\p</subfield><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="y">2001</subfield><subfield code="z">Nara</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Polymere</subfield><subfield code="0">(DE-588)4046699-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Arzneistoffträger</subfield><subfield code="0">(DE-588)4278196-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="8">2\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Maeda, Hiroshi</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kabanov, Alexander</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kataoka, Kazunori</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Okano, Teruo</subfield><subfield code="4">edt</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9781475778403</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9780306474712</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9781475778397</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1007/b105364</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveröffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-2-SBL</subfield></datafield><datafield tag="940" ind1="1" ind2=" "><subfield code="q">ZDB-2-SBL_2000/2004</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-031528529</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">1\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">2\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1007/b105364</subfield><subfield code="l">UBR01</subfield><subfield code="p">ZDB-2-SBL</subfield><subfield code="q">ZDB-2-SBL_2000/2004</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| genre | 1\p (DE-588)1071861417 Konferenzschrift 2001 Nara gnd-content |
| genre_facet | Konferenzschrift 2001 Nara |
| id | DE-604.BV046148352 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T08:36:33Z |
| institution | BVB |
| isbn | 9780306479328 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-031528529 |
| oclc_num | 1119032499 |
| open_access_boolean | |
| owner | DE-355 DE-BY-UBR |
| owner_facet | DE-355 DE-BY-UBR |
| physical | 1 Online-Ressource (VIII, 226 p) |
| psigel | ZDB-2-SBL ZDB-2-SBL_2000/2004 ZDB-2-SBL ZDB-2-SBL_2000/2004 |
| publishDate | 2003 |
| publishDateSearch | 2003 |
| publishDateSort | 2003 |
| publisher | Springer US |
| record_format | marc |
| series2 | Advances in Experimental Medicine and Biology |
| spelling | Polymer Drugs in the Clinical Stage Advantages and Prospects edited by Hiroshi Maeda, Alexander Kabanov, Kazunori Kataoka, Teruo Okano Boston, MA Springer US 2003 1 Online-Ressource (VIII, 226 p) txt rdacontent c rdamedia cr rdacarrier Advances in Experimental Medicine and Biology 519 Proceedings of the International Symposium on Polymer Therapeutics - Recent Progress in Clinics and Future Prospects, held July 13-14, 2001, in Nara, Japan. The technology of polymer science has developed considerably during the past half-century, and this volume describes some of the aspects of this technology that will have a great impact in the future. Among these advances, for example, are gene delivery to specific disease sites and carrier polymers that respond to a stimulus or particular environment. Cancer targeted drug delivery is another focused area of this volume because of the important nature of EPR-effect of polymer drugs in tumor. Included are discussions of as many examples as possible of polymer drugs that have achieved, or are close to clinical use. The concept of "Polymer drugs" here is limited to primarily injectable and water-soluble agents, although also covered are some drugs in micellar form or liposomes. This book is intended for students and researchers in the field of pharmacology who have particular interests in drug delivery, targeting, and formulation, as well as for clinicians such as oncologists who are interested in the field. People who work at regulatory agencies should also be aware such that drugs with great potential are being developed and will be beneficial to many patients, as well as to health insurance agencies because of improved cost effectiveness Pharmacology/Toxicology Polymer Sciences Medical Biochemistry Oncology Pharmacy Toxicology Polymers Biochemistry Oncology Polymere (DE-588)4046699-1 gnd rswk-swf Arzneistoffträger (DE-588)4278196-6 gnd rswk-swf 1\p (DE-588)1071861417 Konferenzschrift 2001 Nara gnd-content Polymere (DE-588)4046699-1 s Arzneistoffträger (DE-588)4278196-6 s 2\p DE-604 Maeda, Hiroshi edt Kabanov, Alexander edt Kataoka, Kazunori edt Okano, Teruo edt Erscheint auch als Druck-Ausgabe 9781475778403 Erscheint auch als Druck-Ausgabe 9780306474712 Erscheint auch als Druck-Ausgabe 9781475778397 https://doi.org/10.1007/b105364 Verlag URL des Erstveröffentlichers Volltext 1\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk 2\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk |
| spellingShingle | Polymer Drugs in the Clinical Stage Advantages and Prospects Pharmacology/Toxicology Polymer Sciences Medical Biochemistry Oncology Pharmacy Toxicology Polymers Biochemistry Oncology Polymere (DE-588)4046699-1 gnd Arzneistoffträger (DE-588)4278196-6 gnd |
| subject_GND | (DE-588)4046699-1 (DE-588)4278196-6 (DE-588)1071861417 |
| title | Polymer Drugs in the Clinical Stage Advantages and Prospects |
| title_auth | Polymer Drugs in the Clinical Stage Advantages and Prospects |
| title_exact_search | Polymer Drugs in the Clinical Stage Advantages and Prospects |
| title_full | Polymer Drugs in the Clinical Stage Advantages and Prospects edited by Hiroshi Maeda, Alexander Kabanov, Kazunori Kataoka, Teruo Okano |
| title_fullStr | Polymer Drugs in the Clinical Stage Advantages and Prospects edited by Hiroshi Maeda, Alexander Kabanov, Kazunori Kataoka, Teruo Okano |
| title_full_unstemmed | Polymer Drugs in the Clinical Stage Advantages and Prospects edited by Hiroshi Maeda, Alexander Kabanov, Kazunori Kataoka, Teruo Okano |
| title_short | Polymer Drugs in the Clinical Stage |
| title_sort | polymer drugs in the clinical stage advantages and prospects |
| title_sub | Advantages and Prospects |
| topic | Pharmacology/Toxicology Polymer Sciences Medical Biochemistry Oncology Pharmacy Toxicology Polymers Biochemistry Oncology Polymere (DE-588)4046699-1 gnd Arzneistoffträger (DE-588)4278196-6 gnd |
| topic_facet | Pharmacology/Toxicology Polymer Sciences Medical Biochemistry Oncology Pharmacy Toxicology Polymers Biochemistry Oncology Polymere Arzneistoffträger Konferenzschrift 2001 Nara |
| url | https://doi.org/10.1007/b105364 |
| work_keys_str_mv | AT maedahiroshi polymerdrugsintheclinicalstageadvantagesandprospects AT kabanovalexander polymerdrugsintheclinicalstageadvantagesandprospects AT kataokakazunori polymerdrugsintheclinicalstageadvantagesandprospects AT okanoteruo polymerdrugsintheclinicalstageadvantagesandprospects |